APOBR
Basic information
Region (hg38): 16:28494643-28498964
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the APOBR gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 24 | 32 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 24 | 10 | 2 |
Variants in APOBR
This is a list of pathogenic ClinVar variants found in the APOBR region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-28494694-C-T | not specified | Uncertain significance (Apr 09, 2024) | ||
16-28494728-G-C | not specified | Uncertain significance (Dec 16, 2023) | ||
16-28495108-G-C | not specified | Uncertain significance (Dec 28, 2023) | ||
16-28495139-C-T | not specified | Uncertain significance (Jul 05, 2024) | ||
16-28495144-C-A | not specified | Uncertain significance (Dec 19, 2022) | ||
16-28495157-G-T | not specified | Uncertain significance (Aug 05, 2024) | ||
16-28495263-A-C | not specified | Uncertain significance (Nov 10, 2024) | ||
16-28495340-C-T | not specified | Uncertain significance (Nov 12, 2024) | ||
16-28495351-G-A | not specified | Uncertain significance (Feb 28, 2024) | ||
16-28495408-A-G | not specified | Likely benign (Apr 01, 2024) | ||
16-28495490-A-G | not specified | Likely benign (Mar 01, 2023) | ||
16-28495501-G-A | not specified | Likely benign (Apr 09, 2024) | ||
16-28495506-A-C | not specified | Uncertain significance (Apr 19, 2024) | ||
16-28495524-G-C | not specified | Uncertain significance (May 03, 2023) | ||
16-28495651-G-A | not specified | Likely benign (Nov 17, 2022) | ||
16-28495658-C-T | not specified | Uncertain significance (Dec 28, 2023) | ||
16-28495682-G-A | not specified | Uncertain significance (Dec 13, 2023) | ||
16-28495763-C-G | not specified | Uncertain significance (May 15, 2023) | ||
16-28495769-G-A | not specified | Uncertain significance (Oct 24, 2023) | ||
16-28495811-G-T | not specified | Uncertain significance (Dec 09, 2023) | ||
16-28495876-G-A | not specified | Uncertain significance (Oct 14, 2023) | ||
16-28495916-C-T | not specified | Uncertain significance (Oct 09, 2024) | ||
16-28495933-G-A | not specified | Uncertain significance (Nov 08, 2024) | ||
16-28495986-C-A | Likely benign (Jun 13, 2018) | |||
16-28495987-G-A | not specified | Likely benign (Sep 27, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
APOBR | protein_coding | protein_coding | ENST00000564831 | 4 | 4322 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
9.40e-8 | 0.996 | 124312 | 0 | 37 | 124349 | 0.000149 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.420 | 545 | 573 | 0.951 | 0.0000330 | 6882 |
Missense in Polyphen | 75 | 89.333 | 0.83956 | 1031 | ||
Synonymous | -1.47 | 274 | 245 | 1.12 | 0.0000160 | 2278 |
Loss of Function | 2.61 | 17 | 33.3 | 0.511 | 0.00000150 | 463 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000865 | 0.000848 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000116 | 0.000110 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000851 | 0.0000803 |
Middle Eastern | 0.000116 | 0.000110 |
South Asian | 0.0000337 | 0.0000327 |
Other | 0.000173 | 0.000164 |
dbNSFP
Source:
- Function
- FUNCTION: Macrophage receptor that binds to the apolipoprotein B48 (APOB) of dietary triglyceride (TG)-rich lipoproteins (TRL) or to a like domain of APOB in hypertriglyceridemic very low density lipoprotein (HTG-VLDL). Binds and internalizes TRL when out of the context of the macrophage. May provide essential lipids to reticuloendothelial cells. Could also be involved in foam cell formation with elevated TRL and remnant lipoprotein (RLP). Mediates the rapid high-affinity uptake of chylomicrons (CM), HTG- VLDL, and trypsinized (tryp) VLDL devoid of APOE in vitro in macrophages. {ECO:0000269|PubMed:10852956, ECO:0000269|PubMed:15591219, ECO:0000269|PubMed:9633939}.;
- Pathway
- VLDL clearance;Plasma lipoprotein clearance;Transport of small molecules;Plasma lipoprotein assembly, remodeling, and clearance
(Consensus)
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.123
- ghis
- 0.409
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Apobr
- Phenotype
Gene ontology
- Biological process
- triglyceride metabolic process;lipid transport;receptor-mediated endocytosis;cholesterol metabolic process;very-low-density lipoprotein particle clearance
- Cellular component
- plasma membrane;membrane;very-low-density lipoprotein particle;low-density lipoprotein particle;chylomicron
- Molecular function
- very-low-density lipoprotein particle receptor activity